Neuroendocrine tumour – Basic Information

Go back

Neuroendocrine tumours are rare cancers that can develop almost anywhere in the body, most commonly in the digestive system, lungs, or pancreas, and while they can be serious, many grow slowly and can be managed for years with the right treatment and care.

Understanding Neuroendocrine Tumours

Neuroendocrine tumours, often called NETs, are unusual cancers that begin in special cells scattered throughout the body. These cells are unique because they share features of both nerve cells, which send and receive signals from the brain, and hormone-making cells that help regulate different body functions. Most neuroendocrine tumours are malignant, which means they are cancerous, but they often behave differently from other cancers people may be more familiar with.[1]

These tumours can appear in many parts of the body, but they have a preference for certain areas. The digestive system is the most common location, particularly the intestines, appendix, rectum, stomach, and pancreas. The lungs are the second most frequent site. Less often, NETs can develop in the thyroid gland, adrenal glands, pituitary gland, or other organs where these special neuroendocrine cells are found.[2]

What makes neuroendocrine tumours particularly complex is their variety. Some NETs are called functional tumours because they produce excess hormones that cause noticeable symptoms. Others are non-functional tumours, meaning they don’t release enough hormones to cause symptoms, though they can still create problems if they grow large enough to press on nearby organs.[1]

How Common Are Neuroendocrine Tumours

Neuroendocrine tumours are considered rare in the medical world. Worldwide, they affect approximately six out of every one hundred thousand people. While this may sound like a very small number, the diagnosis of NETs has been increasing in recent years. This rise is likely not because more people are developing these tumours, but because doctors have better tools and tests to identify them earlier than they could in the past.[2]

These tumours are uncommon in younger people. Children, teenagers, and young adults rarely develop NETs. Most people who receive this diagnosis are between the ages of fifty and sixty years old. Anyone can potentially develop a neuroendocrine tumour, but the risk increases as people get older.[2]

The digestive tract accounts for just over half of all neuroendocrine tumour cases, with the large bowel and appendix being particularly common sites. The lungs are the location for about one quarter of cases. The pancreas and stomach account for smaller percentages. This distribution helps doctors understand where to look when they suspect a patient might have a NET.[8]

What Causes Neuroendocrine Tumours

The exact cause of neuroendocrine tumours remains a mystery to medical researchers. What doctors do know is that NETs begin when neuroendocrine cells start to divide and multiply in an uncontrolled way. Over time, these abnormal cells form masses called tumours. These tumours can then affect the organs where they’re located. However, scientists haven’t yet discovered what triggers this abnormal cell behaviour in the first place.[2]

Unlike some diseases that can be traced to specific behaviours or exposures, neuroendocrine tumours don’t appear to have clear preventable causes. This can be frustrating for patients who naturally wonder “Why did this happen to me?” or “What could I have done differently?” The current understanding is that these tumours develop somewhat randomly in most cases.[8]

Because NETs often grow slowly, the body may have been dealing with them for years before any symptoms appear or before they’re discovered during medical tests. This long, quiet growth period means that by the time someone feels unwell enough to see a doctor, the tumour may have been present for quite some time.[23]

Risk Factors for Neuroendocrine Tumours

While most neuroendocrine tumours develop without any known risk factors, researchers have identified certain rare inherited conditions that increase a person’s chances of developing NETs. These are genetic syndromes caused by changes, or mutations, in specific genes that are passed down through families.[2]

One such condition is called Multiple Endocrine Neoplasia, or MEN for short. This syndrome causes overactive tumours to form in various organs and glands that make hormones. Type 1 MEN, also written as MEN1, is the most common inherited cancer syndrome linked to neuroendocrine tumours. People with this condition need regular monitoring by their doctors.[2]

Other genetic conditions that raise the risk include Von Hippel-Lindau disease and neurofibromatosis. However, it’s important to understand that having one of these syndromes doesn’t guarantee someone will develop a NET—it simply means they face a higher risk than the general population. Most people with NETs do not have any of these genetic conditions. The vast majority of cases are described as “sporadic,” meaning they occur randomly without being related to another disease or inherited from parents.[8]

⚠️ Important
If you have a family history of neuroendocrine tumours or any of the inherited syndromes mentioned above, speak with your doctor about genetic counselling and testing. Early detection through regular screening can make a significant difference in treatment outcomes.

Symptoms of Neuroendocrine Tumours

One of the challenges with neuroendocrine tumours is that they often don’t cause symptoms in their early stages. Many people feel perfectly fine until the tumour grows large enough to press on an organ or until it produces enough hormones to affect how the body works. This is why NETs are sometimes discovered by accident during tests or scans performed for completely unrelated reasons.[2]

When symptoms do appear, they vary greatly depending on where the tumour is located in the body. A NET in the digestive system might cause stomach pain, diarrhoea, nausea, or vomiting. People with lung NETs might experience shortness of breath or a persistent cough, sometimes with blood. General symptoms that can occur regardless of location include feeling unusually tired all the time, which doctors call fatigue.[2]

Some neuroendocrine tumours that produce hormones create a specific pattern of symptoms called carcinoid syndrome. This happens when certain NETs release large amounts of hormones into the bloodstream. People with carcinoid syndrome often experience sudden reddening of the skin, especially on the face and neck, which is called flushing. They may also have severe diarrhoea, painful gas and bloating, or wheezing and shortness of breath. These symptoms can be triggered by specific foods, drinks, or even stress.[1]

It’s crucial to remember that experiencing these symptoms doesn’t automatically mean you have cancer. Many common, less serious conditions can cause similar problems. However, if you notice symptoms that persist or worsen over time, it’s important to discuss them with a healthcare provider. Early investigation can lead to earlier diagnosis if a problem does exist.[2]

Prevention of Neuroendocrine Tumours

Unlike some cancers where specific lifestyle changes can reduce risk—such as not smoking to prevent lung cancer—there are no known preventive measures for neuroendocrine tumours. Because researchers don’t fully understand what causes NETs to develop in the first place, they cannot yet offer specific advice on how to prevent them. This reality can feel discouraging, but it’s important to understand that developing a NET is not a result of something you did or failed to do.[8]

For people with inherited genetic syndromes that increase NET risk, prevention takes a different form. It focuses on early detection rather than stopping tumours from forming. Regular monitoring with blood tests, imaging scans, and check-ups allows doctors to find any tumours when they’re still small and potentially easier to treat. This approach doesn’t prevent NETs, but it can significantly improve outcomes by catching problems early.[8]

General healthy living practices remain valuable even though they don’t specifically prevent NETs. Maintaining a balanced diet, staying physically active, avoiding tobacco, and limiting alcohol all contribute to overall health and may help your body better cope with medical challenges if they arise. Regular medical check-ups also mean that if a NET does develop, there’s a better chance it will be discovered sooner rather than later.[8]

How Neuroendocrine Tumours Affect the Body

To understand how neuroendocrine tumours affect the body, it helps to know what happens when these special cells stop working normally. Healthy neuroendocrine cells throughout the body have important jobs. They create, store, and release small proteins and hormones that the body needs for normal functions. When these cells become cancerous, they can multiply out of control and form tumours.[8]

The way a NET affects the body depends partly on whether it’s functional or non-functional. Functional tumours produce excessive amounts of hormones. These hormones flood into the bloodstream and can cause dramatic effects throughout the body. For example, some NETs produce too much of a substance called serotonin, which affects digestion, blood flow, and mood. This excess can lead to the flushing, diarrhoea, and other symptoms of carcinoid syndrome.[1]

Non-functional tumours cause problems in different ways. As they grow, they take up space and can press on nearby organs. A tumour in the pancreas might block ducts that carry digestive enzymes, leading to pain and digestive problems. A NET in the lung might partially block an airway, making breathing difficult. Some tumours can weaken the wall of blood vessels or organs, potentially causing serious complications.[8]

Like other cancers, neuroendocrine tumours can spread beyond their original location, a process called metastasis. The liver is a particularly common site for NET spread, especially from tumours that started in the digestive system. When NETs reach the liver, they can interfere with this vital organ’s many functions, including filtering blood, producing proteins, and processing nutrients. This is why monitoring and treating liver involvement is often a critical part of NET care.[8]

The growth rate of neuroendocrine tumours varies significantly. Some NETs are described as “low grade” and grow very slowly, sometimes taking years to cause serious problems. Others are “high grade” and grow more aggressively. The grade, along with how differentiated the cells appear under a microscope, helps doctors predict how the tumour might behave and what treatment approach might work best.[6]

⚠️ Important
Understanding your specific type of neuroendocrine tumour, including its location, grade, and whether it’s functional or non-functional, is essential for making informed decisions about your care. Don’t hesitate to ask your healthcare team to explain these details in ways you can understand.

Ongoing Clinical Trials on Neuroendocrine tumour

  • Study to Find the Right Dose and Safety of Lutetium (177Lu) Edotreotide and Arginine-Lysine in Children with Somatostatin Receptor-Positive Tumors

    Recruiting

    1 1
    France Italy Spain
  • Study on the Effect of Octreotide and Lanreotide in Peptide Receptor Radionuclide Therapy for Adults with Neuroendocrine Tumors

    Recruiting

    1 1 1 1
    Investigated diseases:
    The Netherlands
  • Study on Continuing Somatostatin Analogues with Sunitinib, Octreotide, and Lutetium (177Lu) Oxodotreotide for Patients with Neuroendocrine Tumors

    Recruiting

    1 1 1 1
    Belgium The Netherlands
  • Study on Personalized vs Non-Personalized Radionuclide Therapy with 177Lu-Edotreotide and Capecitabine for Patients with Neuroendocrine Tumors

    Recruiting

    1 1 1 1
    Investigated diseases:
    Sweden
  • Study of Cabozantinib in Adults with Advanced Low-Grade Neuroendocrine Tumors

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Germany
  • Study on Long-term Safety of Satoreotide Tetraxetan Lutetium-177 for Patients with Somatostatin Receptor Positive Neuroendocrine Tumors

    Not recruiting

    1 1 1
    Investigated diseases:
    France
  • Study on the Effectiveness of Lutetium (177Lu) Oxodotreotide and Octreotide in Patients with Advanced GEP-NET Tumors (Grade 2 and 3)

    Not recruiting

    1 1 1 1
    Investigated diseases:
    France Germany Italy The Netherlands Spain
  • Study on the Safety of Lutetium (177Lu) Oxodotreotide, L-Lysine Hydrochloride, and L-Arginine Hydrochloride in Adolescents with Neuroendocrine Tumors and PPGLs

    Not recruiting

    1 1 1
    Investigated diseases:
    France Poland Spain

References

https://www.mayoclinic.org/diseases-conditions/neuroendocrine-tumors/symptoms-causes/syc-20354132

https://my.clevelandclinic.org/health/diseases/22006-neuroendocrine-tumors-net

https://www.mdanderson.org/cancerwise/neuroendocrine-tumors–9-things-to-know.h00-159379578.html

https://pmc.ncbi.nlm.nih.gov/articles/PMC10420169/

https://www.cancerresearchuk.org/about-cancer/neuroendocrine-tumours-nets

https://en.wikipedia.org/wiki/Neuroendocrine_tumor

https://www.neuroendocrinecancer.org.uk/neuroendocrine-cancer/understanding-neuroendocrine-cancer/

https://neuroendocrine.org.au/what-are-nets/

https://www.cancer.gov/publications/dictionaries/cancer-terms/def/neuroendocrine-tumor

https://www.mayoclinic.org/diseases-conditions/neuroendocrine-tumors/diagnosis-treatment/drc-20465865

https://www.mdanderson.org/cancer-types/neuroendocrine-tumors/neuroendocrine-tumor-treatment.html

https://my.clevelandclinic.org/health/diseases/22006-neuroendocrine-tumors-net

https://www.cancerresearchuk.org/about-cancer/neuroendocrine-tumours-nets/treatment

https://winshipcancer.emory.edu/cancer-types-and-treatments/neuroendocrine-tumors/treatment.php

https://neuroendocrine.org.au/treatments/

https://pmc.ncbi.nlm.nih.gov/articles/PMC6378464/

https://www.neuroendocrinecancer.org.uk/neuroendocrine-cancer/living-with-neuroendocrine-cancer/

https://netrf.org/old-for-patients/living-with-nets/symptom-management/

https://www.cancerresearchuk.org/about-cancer/neuroendocrine-tumours-nets/living-with/coping

https://www.livingwithnets.com/living-with-neuroendocrine-tumours-nets/diet-and-nutrition/

https://www.webmd.com/cancer/neuroendocrine-tumors-feel-better

https://www.mdanderson.org/cancerwise/neuroendocrine-tumors–9-things-to-know.h00-159379578.html

https://www.uchicagomedicine.org/forefront/cancer-articles/2023/september/pancreatic-nets-patient-chris-meyer

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

https://www.roche.com/stories/terminology-in-diagnostics

FAQ

Are neuroendocrine tumours always cancer?

Most neuroendocrine tumours are malignant, meaning they are cancerous. However, they vary greatly in how aggressive they are. Some grow very slowly and can be managed for many years, while others grow more quickly. The classification depends on how the cells look under a microscope and how fast they’re dividing.

Can neuroendocrine tumours be cured?

When caught at an early stage, neuroendocrine tumours can often be cured with surgery to remove them completely. However, many patients are diagnosed after the cancer has spread to other parts of the body. Even in these cases, the disease and its symptoms can often be controlled for many years with various treatments.

What is carcinoid syndrome and who gets it?

Carcinoid syndrome is a group of symptoms including skin flushing, diarrhoea, and wheezing caused by some neuroendocrine tumours producing large amounts of hormones. It typically occurs in people with functional NETs, particularly those that have spread to the liver. Not everyone with a NET develops carcinoid syndrome.

Why do neuroendocrine tumours take so long to diagnose?

Neuroendocrine tumours often don’t cause symptoms in their early stages, and when symptoms do appear, they can be vague or similar to more common, less serious conditions. Because NETs typically grow slowly, the body may have been dealing with them for years before they cause noticeable problems or are discovered during medical tests.

Is there a genetic test for neuroendocrine tumours?

While most neuroendocrine tumours occur randomly, some are associated with rare inherited genetic syndromes such as Multiple Endocrine Neoplasia Type 1 (MEN1). If you have a family history of NETs or related conditions, your doctor may recommend genetic testing and counselling to assess your risk.

🎯 Key Takeaways

  • Neuroendocrine tumours are rare cancers affecting about 6 in 100,000 people, most commonly appearing in the digestive system, lungs, or pancreas.
  • These tumours arise from special cells that share features of both nerve cells and hormone-producing cells, making them unique among cancers.
  • Most NETs develop randomly without known preventable causes, though rare inherited genetic syndromes can increase risk in some families.
  • Functional NETs produce excess hormones causing noticeable symptoms like flushing and diarrhoea, while non-functional tumours may grow silently for years.
  • The increasing diagnosis rates of NETs are largely due to improved medical imaging and diagnostic tools rather than the disease becoming more common.
  • Symptoms vary widely based on tumour location and may include fatigue, stomach pain, breathing difficulties, or hormonal effects that can be confused with other conditions.
  • When detected early, many neuroendocrine tumours can be cured with surgery, and even advanced cases can often be managed successfully for many years.
  • Understanding your specific NET type, including its grade, location, and functional status, is essential for working with your healthcare team to determine the best treatment approach.